ARCHIVES

BMS, Exelixis To Collaborate On Drug Development.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

NCI blocked groups from phase III Iressa studies.

April 30, 2004

Two New Therapies For Metastatic Cancer Highlighted At AACR Annual Meeting

August 29, 2003

Seventeen of 23 CHOPs Approved For Implementation

July 16, 1982

FDA News: ODAC Clears Photofrin For Microinvasive NSCLC

September 26, 1997

DCE Board Approves Two New Grant Programs, New Contract, Recompetitions Totaling $22 Mil.

March 9, 1990

NIH “RFA Game” Defeats Purpose Of OAM, Advisor Says

September 30, 1994